International Symposium of the Collaborative Research Center 1335

Aberrant Immune Signals in Cancer

02–03 December 2021 • virtual

Conference details

About the Conference

The field of immuno-oncology has introduced novel concepts for the treatment of cancer, that harness the power of the immune system to detect and destroy malignant cells. However, dysfunctional signals in the immune system can suppress antitumor immune responses and drive the development of cancer by creating tumor-promoting inflammatory environments. Moreover, oncogenic mutations within immune cells that deregulate immune receptor signaling pathways are frequent causes of leukemias and lymphomas. 

To address key questions and current concepts on tumor-immune-cell interactions, mechanisms of malignant lymphocyte transformation and ongoing efforts that exploit immune signals for cancer therapies, we will bring together world-leading immunologists and cancer researchers. Furthermore, the event will cover state-of-the-art technologies that explore immune function and metabolism in cancer at the organism, tissue, and cellular level.

Scientific Organizing Committee:
Florian Bassermann, Maike Buchner, Mathias Heikenwälder, Veit Hornung, Hendrik Poeck, Jürgen Ruland, Marc Schmidt-Supprian


Confirmed Speakers

card image

Andrea Ablasser (Ecole polytechnique fédérale de Lausanne/CH)

card image

Theodore Alexandrov (European Molecular Biology Laboratory/DE)

card image

Timothy Chan (Cleveland Clinic/US)

card image

Triantafyllos Chavakis (Technische Universität Dresden/DE)

card image

Florian Greten (Georg-Speyer-Haus/DE)

card image

Nir Hacohen (Broad Institute of MIT and Harvard/US)

card image

Ping-Chih Ho (University of Lausanne/CH)

card image

Michael Hölzel (University Hospital Bonn/DE)

card image

Russel Jones (Van Andel Institute/US)

card image

Ari M. Melnick (Weill Cornell Medicine/US)

card image

Andy J. Minn (Abramson Family Cancer Research Institute/US)

card image

Teresa Palomero (Columbia University/US)

card image

Caetano Reis e Sousa (The Francis Crick Institute/UK)

card image

Salvia Jain (Massachusetts General Hospital Cancer Center/US)